NASDAQ: MMSI

Merit Medical Systems (MMSI) Stock Analysis & Forecast

Nov 13 close

$86.63−0.06 (−0.1%)

Gekko Brief

AI summaryNov 9 close

This week's news centers on Merit Medical's WRAPSODY Cell-Impermeable Endoprosthesis, with multiple releases of real-world data from the WRAP Global registry's AVF cohort. Results show a six-month target lesion primary patency rate of 92.7% and an access circuit primary patency rate of 76.7%, covering 237 patients across 31 sites, with commentary noting these compare favorably to the WAVE pivotal trial data. This follows the Q3 2026 report on 29 October, when Merit Medical posted revenue of $416 million, up 8% year-over-year, with EPS of $1.12 against an estimate of $1.04, though the stock reacted -6.5% to that release.

MMSI closed at $88.42, up 1.4%, sitting above both its 50-day average of $88.23 and its 200-day average of $77.10. The GekkoIndex reads 59, placing the stock in the Neutral zone, down 5.8 over five days. Gekko Fair Value stands at $107.09, leaving price 17.4% below that mark. Over the past six months the stock has returned 46.6%, though the three-month return is -3%.

The next earnings date falls on 23 February 2027, 105 days out, placing it beyond a typical 20-trading-day holding window. No insider, Congress, or unusual options activity appears in the respective 90-day and 30-day windows. Seasonality skews unfavorable, with the next 20 trading days averaging -1.8% over 5 years, rising in 2 of them. Analyst consensus from 9 firms includes 7 buy and 2 hold ratings, with a consensus target of 107 and consensus upside of 21%.

Written by AI from the Nov 9, 2026 close and checked automatically against the figures on this page.

Merit Medical Systems price vs fair value

$101.38$86.63Nov ’25May ’26Nov ’26
Close $86.63200-day averageGekko Fair Value $101.38

Merit Medical Systems quick facts

Market cap
$5.19B
P/E ratio
32.5
Forward P/E
18.8
EPS, TTM
$2.67
Revenue, TTM
$1.61B
Profit margin
9.9%
Dividend yield
—
Beta
0.55
Volume
365,600 avg 744,886
1-year return
−1.7%
Typical daily move
±3.7%
Typical 20-day move
±5.5%
50-day average
$88.02
200-day average
$77.22
Next earnings
Feb 23 after close
Shares outstanding
59.92M
52-week range
$59.74$94.85

Merit Medical Systems swing-trade checklist

Merit Medical Systems scores 3 supportive, 2 mixed and 0 headwinds across the 5 checklist items with data.

Six things swing traders check before a 20-day hold, read from the latest data.

3 supportive2 mixed0 headwinds

  • Trendmixed

    Averages disagree

    Close $86.63 sits between the 50-day ($88.02) and 200-day ($77.22) averages, or the averages disagree.

    See the chart
  • GekkoIndexsupportive

    61.1, Accumulation

    Reading 61.1 is in the Accumulation zone.

    See the GekkoIndex
  • Fair valuesupportive

    14.5% below

    Price is 14.5% below Gekko Fair Value (more than 5% below).

    See fair value
  • Smart moneyno data

    No data

    No insider, Congress or unusual options activity in the window.

    See smart money
  • Earnings risksupportive

    Reports in 100 days

    Next report Feb 23, 2027, 100 days away — outside a typical 20-trading-day hold.

    See earnings
  • Seasonalitymixed

    0.0% on average

    From this point in the calendar, the next 20 trading days averaged 0% over 5 years, rising in 3 of them.

    See seasonality

A description of current data, not a recommendation. How this page works

Merit Medical Systems stock chart and price history

Merit Medical Systems closed at $86.63 on Nov 13, 2026, −1.7% over the past year, inside a 52-week range of $59.74 to $94.85.

Close50-day average200-day averageVolume
Merit Medical Systems share price, past year, with 50-day and 200-day moving averages and volume$60$70$80$90DecJan 2026FebMarAprMayJunJulAugSepOctNov86.63

Use the left and right arrow keys to read daily values.

Performance Breakdown

1 month
−3.3%
3 months
−3.5%
6 months
+41.2%
1 year
−1.7%
The full MMSI chart adds GekkoIndex, insider, options, Congress and hedge fund markers, plus TrendCandles™.Open MMSI in Gekko

Follow Merit Medical Systems through every session

Put MMSI on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.

Track MMSI in GekkoFree for 7 days. No credit card required.

About Merit Medical Systems

Merit Medical Systems designs and builds disposable devices used by clinicians during diagnostic, therapeutic and interventional work, with a strong presence in cardiology, radiology, oncology, critical care and endoscopy. It has built a wide catalog of tools meant to support treatment of blood vessels, organs and heart conditions, covering everything from angiography to hemostasis.

Operations are split between a Cardiovascular division and an Endoscopy division. Product lines take in access and monitoring devices, electrophysiology and rhythm-management equipment, procedure trays, coated tubing, sensor parts used in microelectromechanical systems, stents for the airway, dilation balloons and various gastroenterology and bronchoscopy kits. Hospitals, physicians, nurses and technicians across different treatment settings make up its customer base, and goods move through an in-house sales team along with outside distributors, OEM agreements and companies that assemble custom procedure trays, serving buyers both at home and abroad.

The company traces back to 1987 and runs its main offices out of South Jordan, Utah. Its stock trades on the NASDAQ under the ticker MMSI.

Listed
NASDAQ
Sector
Health technology
Industry
Medical specialties
Website
merit.com

Merit Medical Systems GekkoIndex: the smart money zone

Merit Medical Systems’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 61.1, in the Accumulation zone, up 1.4 points over five sessions.

010061.1Accumulation

Up 1.4 points over five sessions, from the Neutral zone.

Reading for Nov 13, 2026

What followed past readings in each zone

ZoneReadings5 days10 days20 days50 days
Buying42−0.3%−0.6%−0.2%+4.3%
Accumulation (current zone)225+0.5%+0.9%+1.8%+1.8%
Neutral3960.0%0.0%+0.2%+1.7%
Distribution30−0.1%+0.5%−0.9%+1.2%
Selling9Too few readings yet

Average MMSI share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Accumulation readings averaged +2.0% over 20 days. Past behaviour doesn’t guarantee future results.

Accumulation zone: Institutional interest building. About the five zones →

See every daily GekkoIndex reading plotted over the MMSI price, zone by zone.Track MMSI in Gekko

Is Merit Medical Systems stock overvalued? Gekko Fair Value

Merit Medical Systems trades 14.5% below Gekko Fair Value of $101.38, so the shares are undervalued on Gekko’s estimate.

Gekko’s own estimate of what Merit Medical Systems shares are worth, recalculated every trading day.

$101.38

Gekko Fair Value, Nov 14, 2026

14.5% Undervalued

At the end of Aug 2026 the price was 18.3% below the estimate.

Gekko Fair ValueShare price, month end
$101$87Aug 2026SepOctNov 2026

How Gekko Fair Value works →

Gekko Fair Value on every chart, with the gap to price updating daily.Open MMSI in Gekko

Merit Medical Systems insider and Congress trading

No open-market insider purchases were filed for Merit Medical Systems, and no Congress trades were disclosed, in the last 90 days.

Plus buybacks, unusual options and fund positions, each dated to when it became public.

Insider buying last 90 days

No open-market insider purchases were filed for MMSI in the last 90 days.

From Form 4 filings, dated to when each was filed.

Every MMSI insider filing, plotted on the chart in Gekko.Open MMSI in Gekko

Congress trades last 90 days

No trades in MMSI were disclosed by members of Congress in the last 90 days.

From congressional disclosures, which report amounts as ranges.

Congress disclosures for MMSI, plotted on the chart in Gekko.Open MMSI in Gekko

Merit Medical Systems earnings: next date and track record

Merit Medical Systems reports on Feb 23, 2027, after the close (100 days away), and beat the EPS estimate in 8 of its last 8 reports.

8 of 8reports beat the EPS estimate
±4.1%average move across the report
4 of 8reports followed by a gain

Share-price move across each report

−3.0%Feb ’25+0.9%Apr ’25+2.4%Jul ’25+7.6%Oct ’25−2.9%Feb ’26−4.4%Apr ’26+5.2%Jul ’26−6.5%Oct ’26

Last earnings call, Oct 29, 2026 AI summary

What they said
MMSI reported Q3 2026 total revenue of $416 million, up 8% year-over-year, exceeding guidance high end. Organic growth of 9% was driven by 8% growth in foundational products and 11% in therapeutic products. Non-GAAP operating margin expanded 160 bps to 21.3%, non-GAAP EPS grew 22% YoY, and free cash flow reached $53 million. ViewPoint Medical integration progressing with strong academic institution pipeline.
Guidance
Management raised full-year 2026 guidance following stronger-than-expected Q3 results. The company remains confident in delivering attractive constant currency growth, improved profitability, and solid cash flow for the full year.
ReportedEPSSurpriseRevenueSurpriseMove
Oct 29, 2026$1.12
est $1.04
+7.7%$416.2M
est $410.6M
+1.4%−6.5%
Jul 30, 2026$1.09
est $0.85
+28.2%$418.8M
est $405.2M
+3.4%+5.2%
Apr 30, 2026$0.94
est $0.83
+13.3%$381.9M
est $377.6M
+1.1%−4.4%
Feb 24, 2026$1.04
est $0.95
+9.5%$393.9M
est $389.9M
+1.0%−2.9%
Oct 30, 2025$0.92
est $0.82
+12.2%$384.2M
est $388.3M
−1.1%+7.6%
Jul 30, 2025$1.01
est $0.86
+17.4%$382.5M
est $371.5M
+3.0%+2.4%
Apr 24, 2025$0.86
est $0.75
+14.7%$355.4M
est $352.5M
+0.8%+0.9%
Feb 25, 2025$0.93
est $0.83
+12.0%$355.2M
est $351.5M
+1.0%−3.0%

“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.

Merit Medical Systems stock forecast and analyst price targets

Analysts’ average 12-month price target for Merit Medical Systems is $107.00, +23.5% from the last close, from 9 firms rating the stock in the last 90 days.

$107.00consensus 12-month target, +23.5% from the last close
Low $90High $121
Buy7
Hold2
Sell0

Each firm’s latest rating in the last 90 days: 9 firms.

Latest analyst actions

DateFirmRatingTargetvs price
Oct 30Robert W. BairdBuy, maintained$107+23.5%
Oct 30Canaccord GenuityBuy, reiterated$121+39.7%
Oct 30Piper SandlerBuy, reiterated$108+24.7%
Oct 30BarringtonBuy, maintained$116+33.9%
Oct 30BTIGBuy, maintained$110+27.0%
+1.8%average 20-day move after past Accumulation readings
0.0%average move over the next 20 trading days in the last 5 years
±3.7%typical daily move, from the 14-day average range

Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.

Merit Medical Systems seasonality: the next 20 trading days

Over the next 20 trading days from Nov 14, Merit Medical Systems averaged 0.0% across the last 5 years, rising in 3 of them.

Next 20 trading days, by year

−9.7%2021+7.2%2022−2.1%2023+1.5%2024+1.6%2025

Average move and hit rate

WindowAverageYears higher
Next 5 trading days+1.1%4 of 5
Next 10 trading days−1.4%3 of 5
Next 15 trading days−1.2%2 of 5
Next 20 trading days0.0%3 of 5
Next 30 trading days−0.3%3 of 5

For scale, MMSI’s typical 20-trading-day move in either direction is about 5.5%.

Merit Medical Systems market cap and key statistics

Merit Medical Systems’s market cap is $5.19B, with a P/E ratio of 32.5 and revenue of $1.61B over the last twelve months.

Valuation

Market cap
$5.19B
P/E ratio
32.5
Forward P/E
18.8
EPS, TTM
$2.67
Gekko Fair Value
$101.38

Trading

Volume
365,600
Avg volume, 20 days
744,886
52-week high
$94.85
52-week low
$59.74
Shares outstanding
59.92M

Financials

Revenue, TTM
$1.61B
Profit margin
9.9%
Return on equity
9.8%
Quarterly earnings growth, YoY
+52.2%

Risk and income

Beta
0.55
Typical daily move
±3.7%
Typical 20-day move
±5.5%

Merit Medical Systems peers

Merit Medical Systems’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.

StockTodayGekkoIndex zonevs Fair Value
TMOThermo Fisher Scientific−0.2%Neutral15.0% above
ABTAbbott Laboratories+0.3%Neutral10.5% below
DHRDanaher0.0%Neutral4.7% above
ISRGIntuitive Surgical0.0%Neutral17.5% above
MDTMedtronic+0.7%Neutral14.2% below
SYKStryker−2.0%Neutral0.1% below

A peer links to its own page where one exists.

In the Buying zone today

Reporting earnings this week

Popular on Gekko

More stocks in Medical specialties

Merit Medical Systems stock FAQ

What is Merit Medical Systems’s market cap?

Merit Medical Systems’s market cap is $5.19B at the Nov 13, 2026 close of $86.63, with 59.92M shares outstanding. The shares trade on a P/E ratio of 32.5.

What is the Merit Medical Systems stock forecast?

The consensus analyst 12-month price target for Merit Medical Systems is $107.00, +23.5% from the last close. Of the 9 firms that rated the stock in the last 90 days, 7 rate it a buy, 2 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.

Is Merit Medical Systems stock overvalued or undervalued?

On Gekko’s estimate Merit Medical Systems is undervalued: the Nov 13, 2026 close of $86.63 is 14.5% below Gekko Fair Value of $101.38. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.

When does Merit Medical Systems report earnings next?

Merit Medical Systems is expected to report on Feb 23, 2027, after the market closes (100 days away). Analysts expect earnings of $1.11 per share on revenue of $422.8M. Merit Medical Systems beat the earnings estimate in 8 of its last 8 reports, moving 4.1% on average across the report.

What is Merit Medical Systems’s 52-week high and low?

Merit Medical Systems’s 52-week high is $94.85 and its 52-week low is $59.74; it closed at $86.63 on Nov 13, 2026, −1.7% over the past year. Over the last five years the shares peaked at $111.45 on Jan 31, 2025.

Is Merit Medical Systems stock a buy right now?

Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (gekkoindex, fair value and earnings risk), 2 as mixed (trend and seasonality). The checklist is a description of current data, not a recommendation.

How this page works

During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →

See Merit Medical Systems the way Gekko members do

Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.

Join 1,475 other traders using Gekko

Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.